Irish Jian 4
4 · Metagenomi Therapeutics, Inc. · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
Metagenomi (MGX) CEO Jian Irish Sells 3,737 Shares
What Happened Jian Irish, President and Chief Executive Officer of Metagenomi Therapeutics (MGX), disposed of 3,737 shares on June 5, 2026 at $1.30 per share for proceeds of $4,854. The filing states this sale was an automatic disposition to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs) and was not a volitional trade by the reporting person.
Key Details
- Transaction date and price: June 5, 2026 — sale of 3,737 shares at $1.30 each (total ≈ $4,854).
- Reason/code: Tax withholding on vested RSUs (footnote F1) — sale not initiated as a discretionary market trade.
- Related holdings noted: filing includes 1,500 shares acquired under the company ESPP on May 29, 2026 (F2); certain shares are held in irrevocable trusts with disclaimers of beneficial ownership (F3, F4).
- Filing: Report filed on June 10, 2026 for a June 5 transaction (file appears to have been filed after the standard two-business-day Form 4 deadline).
Context Tax-withholding sales of vested RSUs are common and generally reflect routine payroll tax handling rather than a signal of insider sentiment. The filing clarifies the sale was to cover withholding for RSUs granted April 1, 2024 and April 1, 2025. The report does not specify total shares beneficially owned after the transaction.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-05$1.30/sh−3,737$4,854→ 377,533 total
- 292,714(indirect: By Trust)
Common Stock
[F3] - 292,713(indirect: By Trust)
Common stock
[F4]
Footnotes (4)
- [F1]These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.
- [F2]Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 29, 2026.
- [F3]Shares held by the Bruce Irish 2023 Irrevocable Trust FBO Jian Irish. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]Shares held by the Jian Irish 2023 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.